Abstract:ABSTRACT The antibacterial activity of rifamycins specifically relies on the inhibition of transcription by directly binding to the β-subunit of bacterial DNA-dependent RNA polymerase (RNAP). However, its killing efficacy is substantially diminished in most gram-negative bacteria. To systematically reveal the cellular functions that counteract rifamycin-mediated killing in the gram-negative model organism Escherichia coli , we performed a genome-wide Tn5 transposon-mediated screen to identify mutants with altered susceptibility to rifampicin. Combined with targeted gene knockouts, our results showed that the β-barrel assembly machinery plays a crucial role in restricting rifampicin from entering the cell, whereas mutants deficient in other cellular permeability barriers, such as lipopolysaccharide and enterobacterial common antigen, had no such effect. At bactericidal concentrations, the killing efficacy of rifampicin was strongly influenced by cellular functions, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. Although iron acquisition de facto has a strong impact or dependence on cellular redox, our results suggest that their effects on rifampicin efficacy do not rely on hydroxyl radical formation. We provide evidence that maintenance of DNA replication and transcription-coupled nucleotide excision repair protects E. coli cells against rifampicin killing. Moreover, our results showed that sustained aerobic respiration and carbon catabolism diminish rifampicin’s killing efficacy, and this effect relies on the inhibition of transcription but not on translation. These findings suggest that the killing efficacy of rifamycins is largely determined by cellular responses upon the inhibition of RNAP and may expand our knowledge of the action mechanisms of rifamycins. IMPORTANCE Rifamycins are a group of antibiotics with a wide antibacterial spectrum. Although the binding target of rifamycin has been well characterized, the mechanisms underlying the discrepant killing efficacy between gram-negative and gram-positive bacteria remain poorly understood. Using a high-throughput screen combined with targeted gene knockouts in the gram-negative model organism Escherichia coli , we established that rifampicin efficacy is strongly dependent on several cellular pathways, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. In addition, we provide evidence that these pathways modulate rifampicin efficacy in a manner distinct from redox-related killing. Our findings provide insights into the mechanism of rifamycin efficacy and may aid in the development of new antimicrobial adjuvants.

Rifampin Resistance Mutations in the Rpob Gene of Enterococcus Faecalis Impact Host Macrophage Cytokine Production.

Rifampicin-Resistance Mutations in the Rpob Gene in Bacillus Velezensis CC09 Have Pleiotropic Effects.

Rifampin-resistance-associated Mutations in the Rifampin-Resistance-determining Region of the Rpob Gene of Mycobacterium Tuberculosis Clinical Isolates in Shanghai, PR China.

Global Effect of an RNA Polymerase Β-Subunit Mutation on Gene Expression in the Radiation-Resistant Bacterium Deinococcus Radiodurans

Molecular Characterization of Rifr Mutations in Enterococcus Faecalis and Enterococcus Faecium.

rpoB mutations conferring rifampicin-resistance affect growth, stress response and motility in Vibrio vulnificus

Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates

Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli

Mycobacterium Tuberculosis Carrying a Rifampicin Drug Resistance Mutation Reprograms Macrophage Metabolism Through Cell Wall Lipid Changes

The development of variation-based rifampicin resistance in Staphylococcus aureus deciphered through genomic and transcriptomic study

Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons

[Investigation of Drug-Resistance to Rifampin and Rpob Gene Sequence Analysis of Mycobacterium Abscessus].

A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis.

Genetic and physiological characterization of rpoB mutations that activate antibiotic production in Streptomyces lividans.

Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China.

[Mutagenesis of Ion Beam Implantation and Identification of Two New Rifampicin Resistance Determining Sites in Rpob Gene in Escherichia Coli].

A Novel Marrab Operon Contributes To The Rifampicin Resistance In Mycobacterium Smegmatis

Response Regulator Protein CiaR Regulates the Transcription of Ccn-Micrornas and Β-Lactam Antibiotic Resistance Conversion of Streptococcus Pneumoniae

Evolution and evolvability of rifampicin resistance across the bacterial tree of life

Constitutive Activation of RpoH and the Addition of L-arabinose Influence Antibiotic Sensitivity of PHL628 E. coli

A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection